RHT 3.45% 5.6¢ resonance health limited

announcement trading halt, page-99

  1. 2,686 Posts.
    lightbulb Created with Sketch. 341
    FibroScan® is a non-invasive device that assesses the ‘hardness’ (or stiffness) of the liver via the technique of transient elastography. Liver hardness is evaluated by measuring the velocity of a vibration wave (also called a ‘shear wave’) generated on the skin. Shear wave velocity is determined by measuring the time the vibration wave takes to travel to a particular depth inside the liver.1 A graphical representation of this is provided on the screen (Figure 1). Because fibrous tissue is harder than normal liver, the degree of hepatic fibrosis can be inferred from the liver hardness. To improve test reliability a minimum of 10 valid readings, with at least a 60% success rate and an interquartile range of =30% of the median value, are taken with the results expressed in kilopascals (kPa).1,2
    NOTE . 10 valid readings
    With at LEAST 60% success rate.
    In addition , the fatter the patient , the less accurate the tests.
 
watchlist Created with Sketch. Add RHT (ASX) to my watchlist
(20min delay)
Last
5.6¢
Change
-0.002(3.45%)
Mkt cap ! $25.91M
Open High Low Value Volume
5.9¢ 5.9¢ 5.6¢ $3.71K 64.01K

Buyers (Bids)

No. Vol. Price($)
1 73500 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.9¢ 33800 2
View Market Depth
Last trade - 15.26pm 17/10/2024 (20 minute delay) ?
RHT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.